Posted by Alan on October 10, 2002, at 22:31:14
In reply to Re: AD's vs. Bzds for Anxiety disorders » Alan, posted by pharmrep on October 9, 2002, at 22:22:18
> *** come on alan..if the pharm industry wanted to make money in bzds vs ad's it probably could...it just chooses to focus on ad's because there is more to work with, and more people to aim for...and i believe a proven track record for effectiveness...
===============================================Would you please elaborate further about the need to focus on AD's at the expense of Bzd's in the treatment of anxiety disorders....causing doctors to mistakenly offer only AD monotherapy instead of both BZD monotherapy AND AD monotherapy on equal footing for their patients' clinical trials?
poster:Alan
thread:109458
URL: http://www.dr-bob.org/babble/20021006/msgs/123154.html